Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

YD Bio Ltd

CIK 0002011674YDESYDESW· quarter ending 2026-06-30
Shares outstanding
70,789,261
Held by 13F filers
284,369
0.4% of shares outstanding
Holders
13
+5 vs 2026-03-31 · 5 new, 0 exited
Value
$640K
shares +78.3% vs prior quarter

Share classes (cover page of the 20-F filed 2026-04-30, as of 2025-12-31)

ClassListedShares outstandingHeld by 13F filers% of classHoldersCUSIP
Common stockYDES · NASDAQ70,789,261284,3690.4%13G98301107

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine
CountCUSIPClass (as filers write it)HoldersShares heldClass shares% of classValueOptionsMapped via
G98301107COM13284,36970,789,2610.4%$640K—13DGholders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings.

Top holders (13 of 13 · G98301107)

change vs 2026-03-31
#FilerShares% of classValueChange
1Garrett Wealth Advisory Group, LLC84,6300.12%$190KNEW
2GEODE CAPITAL MANAGEMENT, LLC62,7140.09%$141K+2,478 (+4.1%)
3Cypress Capital Management LLC (WY)33,6900.05%$76K+3,000 (+9.8%)
4Cerity Partners LLC32,4060.05%$73K—
5CITADEL ADVISORS LLC30,1060.04%$68K+10,656 (+54.8%)
6JANE STREET GROUP, LLC21,4230.03%$48KNEW
7UBS Group AG12,3840.02%$28K+756 (+6.5%)
8WOLVERINE ASSET MANAGEMENT LLC4,8860.01%$11K—
9SkyView Investment Advisors, LLC1,7770.00%$4KNEW
10MORGAN STANLEY1600.00%$360-63 (-28.3%)
11ROYAL BANK OF CANADA1170.00%$0NEW
12WELLS FARGO & COMPANY/MN750.00%$169NEW
13FMR LLC10.00%$2—

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting personFormFiledEventShares% of class
Ethan ShenSCHEDULE 13G/A2026-02-172026-02-1754,345,01177.06%
YD Biopharma Holding LimitedSCHEDULE 13G/A2026-02-172026-02-1743,120,85861.15%
EG Biomed LimitedSCHEDULE 13G2025-12-162025-09-3011,224,15315.9%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.